PT852492E - Sistema matricial transdermico - Google Patents

Sistema matricial transdermico

Info

Publication number
PT852492E
PT852492E PT96932647T PT96932647T PT852492E PT 852492 E PT852492 E PT 852492E PT 96932647 T PT96932647 T PT 96932647T PT 96932647 T PT96932647 T PT 96932647T PT 852492 E PT852492 E PT 852492E
Authority
PT
Portugal
Prior art keywords
weight
parts
pct
group
sec
Prior art date
Application number
PT96932647T
Other languages
English (en)
Inventor
Eric Teillaud
Marie-Christine Math
Bruno Bevan
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of PT852492E publication Critical patent/PT852492E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Telephonic Communication Services (AREA)
  • Soy Sauces And Products Related Thereto (AREA)
  • Steroid Compounds (AREA)
PT96932647T 1995-09-27 1996-09-25 Sistema matricial transdermico PT852492E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9511326A FR2739032B1 (fr) 1995-09-27 1995-09-27 Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base d'eva, procede de preparation et utilisation en therapeutique

Publications (1)

Publication Number Publication Date
PT852492E true PT852492E (pt) 2002-05-31

Family

ID=9482961

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96932647T PT852492E (pt) 1995-09-27 1996-09-25 Sistema matricial transdermico

Country Status (25)

Country Link
US (1) US6013276A (pt)
EP (1) EP0852492B1 (pt)
JP (1) JPH11514988A (pt)
KR (1) KR19990063732A (pt)
CN (1) CN1083259C (pt)
AT (1) ATE209031T1 (pt)
AU (1) AU702542B2 (pt)
BG (1) BG102322A (pt)
BR (1) BR9610665A (pt)
CA (1) CA2233162A1 (pt)
CZ (1) CZ95398A3 (pt)
DE (1) DE69617252T2 (pt)
DK (1) DK0852492T3 (pt)
EE (1) EE9800082A (pt)
ES (1) ES2170266T3 (pt)
FR (1) FR2739032B1 (pt)
HU (1) HUP9900375A3 (pt)
IL (1) IL123594A0 (pt)
NO (1) NO981252D0 (pt)
NZ (1) NZ319181A (pt)
PL (1) PL325644A1 (pt)
PT (1) PT852492E (pt)
SK (1) SK282613B6 (pt)
TR (1) TR199800563T1 (pt)
WO (1) WO1997011687A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10211832A1 (de) * 2002-03-16 2003-10-02 Lohmann Therapie Syst Lts Hormonhaltiges transdermales therapeutisches System mit einem Wirkstoffreservoir auf der Basis von Vinylacetat-Vinylpyrrolidon-Copolymer mit verbesserter Kohäsion
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
CA2856520C (en) 2011-11-23 2021-04-06 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
CA3020153A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
US11633405B2 (en) 2020-02-07 2023-04-25 Therapeuticsmd, Inc. Steroid hormone pharmaceutical formulations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3049628C2 (de) * 1980-12-31 1982-10-21 Basf Ag, 6700 Ludwigshafen Verfahren zur Überwachung des Entstehens und Fortschreitens von Rissen in Maschinenteilen und Bauteilen sowie eine Vorrichtung zur Durchführung des Verfahrens
JPS58189115A (ja) * 1982-04-30 1983-11-04 Kowa Co 外用剤
US4816258A (en) * 1987-02-26 1989-03-28 Alza Corporation Transdermal contraceptive formulations
FR2612785A1 (fr) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique Dispositif auto-adhesif d'administration d'un principe actif par voie percutanee
JPH03275619A (ja) * 1990-03-23 1991-12-06 Nitsusui Seiyaku Kk 外用剤組成物
US5286490A (en) * 1990-05-04 1994-02-15 Colgate-Palmolive Company Transdermal fluoride medication
US5122382A (en) * 1990-10-29 1992-06-16 Alza Corporation Transdermal contraceptive formulations, methods and devices
US5453279A (en) * 1992-04-21 1995-09-26 Tbs Laboratories, Inc. Enhancing transdermal absorption compositions; transdermal dosage form; and process
FR2717688B1 (fr) * 1994-03-28 1996-07-05 Lhd Lab Hygiene Dietetique Système matriciel transdermique d'administration d'un oestrogène et/ou un progestatif à base d'EVA.

Also Published As

Publication number Publication date
AU702542B2 (en) 1999-02-25
DE69617252T2 (de) 2002-07-25
CA2233162A1 (en) 1997-04-03
MX9802327A (es) 1998-08-30
PL325644A1 (en) 1998-08-03
AU7134996A (en) 1997-04-17
NO981252L (no) 1998-03-19
ES2170266T3 (es) 2002-08-01
CN1083259C (zh) 2002-04-24
IL123594A0 (en) 1998-10-30
NZ319181A (en) 1998-10-28
DE69617252D1 (de) 2002-01-03
EP0852492B1 (fr) 2001-11-21
WO1997011687A1 (fr) 1997-04-03
BR9610665A (pt) 1999-07-13
FR2739032A1 (fr) 1997-03-28
EE9800082A (et) 1998-10-15
BG102322A (en) 1998-10-30
SK40698A3 (en) 1998-09-09
CN1197390A (zh) 1998-10-28
KR19990063732A (ko) 1999-07-26
ATE209031T1 (de) 2001-12-15
JPH11514988A (ja) 1999-12-21
NO981252D0 (no) 1998-03-19
HUP9900375A2 (hu) 1999-06-28
SK282613B6 (sk) 2002-10-08
HUP9900375A3 (en) 1999-11-29
CZ95398A3 (cs) 1998-07-15
US6013276A (en) 2000-01-11
FR2739032B1 (fr) 1997-11-21
DK0852492T3 (da) 2002-05-13
TR199800563T1 (xx) 1998-06-22
EP0852492A1 (fr) 1998-07-15

Similar Documents

Publication Publication Date Title
PT852492E (pt) Sistema matricial transdermico
NO981315L (no) Transdermalt matrikssystem
DE58909793D1 (de) Neue Benzopyran-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung sowie die Verbindungen enthaltenden Zubereitungen
DE69030180D1 (en) Bakteriochlorophyll-a-derivate bei fotodynamischer therapie
MX9602563A (es) Compuestos carbociclicos.
NZ238207A (en) Enantioselective preparation of phenylisoserine derivatives and baccatin derivatives prepared therefrom
IE830233L (en) Imidazoles
NO982987L (no) Amidinoproteasehemmere
DK164326C (da) 6,6-ethylen-15,16-methylen-3-oxo-17alfa-pregn-4-en-21,17-carbolactoner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende dem
ES8404850A1 (es) Procedimiento para la obtencion de 2-nitro-1,1-etendiaminas
JO1589B1 (en) Ketones (quaternary hydroimidazo (4.1) benzo-diazepine-2) anti-viral
DE59610819D1 (de) Arzneistoffe zur selektiven bekämpfung von tumorgewebe
UA20112A (uk) Спосіб підвищеhhя скоротливої активhості ішемізоваhого міокарду у хворих hа ішемічhу хворобу серця
NO945093L (no) Målrettet avgivelse av vekstfaktorer for benregenerering
ES2062087T3 (es) Insecticidas y parasiticidas que pueden derivarse de la milbemicina.
JPS56164178A (en) Preparation of 4-hydroxy-1,3-benzodioxole
EP0346133A3 (en) Process for the preparation of macrolide compounds
TH9839EX (th) อนุพันธ์โดโลเบนโซควิโนลีน,การเตรียมสารเหล่านั้นและการใช้สารเหล่าเป็นยาต่อต้านอาการหัวใจเต้นไม่ปกติ
TW358093B (en) 4, 10 <beta>-diacetony-2<alpha>-benzoyloxy-5<beta>, 20-epocy-1-hydroxy9-oxo-19-norcylopropa[g]tax-11-en-13<alpha>-yl(2r,3s)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylropinate dihydrate and a process for is preparation
JPS5414998A (en) Prostaglandin i2 analog and its preparation
TH9839A (th) อนุพันธ์โดโลเบนโซควิโนลีน,การเตรียมสารเหล่านั้นและการใช้สารเหล่าเป็นยาต่อต้านอาการหัวใจเต้นไม่ปกติ